Literature DB >> 25373710

[Therapy of aortic valve stenosis].

J D Widder1, J Bauersachs.   

Abstract

Calcific aortic stenosis is the most frequent valve disorder in the western world. It is a degenerative and chronic progressive disease in the elderly with increasing prevalence due to the demographic development in the population. As there is no medical therapy, the only option in severe aortic stenosis is valve replacement. Echocardiography is the diagnostic tool to assess aortic stenosis severity and morphology of the valve. Aortic stenosis is severe if the valve area is <1.0 cm(2), valve index <0.6 cm(2)/m(2) body surface, mean gradient >40 mmHg, and peak velocity >4.0 m/s. The entity of low flow, low gradient aortic stenosis is complex, and diagnosis and therapy are still challenging. Asymptomatic patients have a good prognosis, but must be reevaluated on a regular basis for the onset of symptoms or signs of progression. If one of the classical symptoms dyspnea and fatigue, angina pectoris or syncope occurs prognosis worsens dramatically and valve replacement is indicated. Gold standard therapy for aortic stenosis is surgical valve replacement. For high-risk patients (older age and severe comorbidities), transcatheter aortic valve implantation (TAVI) is established as standard therapy.

Entities:  

Mesh:

Year:  2014        PMID: 25373710     DOI: 10.1007/s00108-014-3555-1

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  23 in total

Review 1.  [Transcatheter aortic valve implantation (TAVI)].

Authors:  H Möllmann; W-K Kim; T Walther; C Hamm
Journal:  Internist (Berl)       Date:  2013-12       Impact factor: 0.743

2.  Early and intermediate outcome after aortic valve replacement with a sutureless bioprosthesis: Results of a multicenter study.

Authors:  Antonino S Rubino; Giuseppe Santarpino; Herbert De Praetere; Keiichiro Kasama; Magnus Dalén; Ulrik Sartipy; Jarmo Lahtinen; Jouni Heikkinen; Wanda Deste; Francesco Pollari; Peter Svenarud; Bart Meuris; Theodor Fischlein; Carmelo Mignosa; Fausto Biancari
Journal:  J Thorac Cardiovasc Surg       Date:  2014-04-04       Impact factor: 5.209

3.  Transcatheter versus surgical aortic-valve replacement in high-risk patients.

Authors:  Craig R Smith; Martin B Leon; Michael J Mack; D Craig Miller; Jeffrey W Moses; Lars G Svensson; E Murat Tuzcu; John G Webb; Gregory P Fontana; Raj R Makkar; Mathew Williams; Todd Dewey; Samir Kapadia; Vasilis Babaliaros; Vinod H Thourani; Paul Corso; Augusto D Pichard; Joseph E Bavaria; Howard C Herrmann; Jodi J Akin; William N Anderson; Duolao Wang; Stuart J Pocock
Journal:  N Engl J Med       Date:  2011-06-05       Impact factor: 91.245

Review 4.  Aortic stenosis.

Authors:  J Ross; E Braunwald
Journal:  Circulation       Date:  1968-07       Impact factor: 29.690

5.  Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up.

Authors:  Patricia A Pellikka; Maurice E Sarano; Rick A Nishimura; Joseph F Malouf; Kent R Bailey; Christopher G Scott; Marion E Barnes; A Jamil Tajik
Journal:  Circulation       Date:  2005-06-13       Impact factor: 29.690

6.  Transcatheter aortic-valve replacement with a self-expanding prosthesis.

Authors:  David H Adams; Jeffrey J Popma; Michael J Reardon; Steven J Yakubov; Joseph S Coselli; G Michael Deeb; Thomas G Gleason; Maurice Buchbinder; James Hermiller; Neal S Kleiman; Stan Chetcuti; John Heiser; William Merhi; George Zorn; Peter Tadros; Newell Robinson; George Petrossian; G Chad Hughes; J Kevin Harrison; John Conte; Brijeshwar Maini; Mubashir Mumtaz; Sharla Chenoweth; Jae K Oh
Journal:  N Engl J Med       Date:  2014-03-29       Impact factor: 91.245

7.  Sutureless perceval aortic valve replacement: results of two European centers.

Authors:  Thierry A Folliguet; François Laborde; Konstantinos Zannis; Gabriel Ghorayeb; Axel Haverich; Malakh Shrestha
Journal:  Ann Thorac Surg       Date:  2012-05       Impact factor: 4.330

8.  Predictors of outcome in severe, asymptomatic aortic stenosis.

Authors:  R Rosenhek; T Binder; G Porenta; I Lang; G Christ; M Schemper; G Maurer; H Baumgartner
Journal:  N Engl J Med       Date:  2000-08-31       Impact factor: 91.245

9.  Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.

Authors:  Anne B Rossebø; Terje R Pedersen; Kurt Boman; Philippe Brudi; John B Chambers; Kenneth Egstrup; Eva Gerdts; Christa Gohlke-Bärwolf; Ingar Holme; Y Antero Kesäniemi; William Malbecq; Christoph A Nienaber; Simon Ray; Terje Skjaerpe; Kristian Wachtell; Ronnie Willenheimer
Journal:  N Engl J Med       Date:  2008-09-02       Impact factor: 91.245

10.  Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial.

Authors:  Kwan Leung Chan; Koon Teo; Jean G Dumesnil; Andy Ni; James Tam
Journal:  Circulation       Date:  2010-01-04       Impact factor: 29.690

View more
  1 in total

1.  Comparison of the levels of depression and anxiety in elderly aortic stenosis patients treated with surgical or transcatheter aortic valve replacement.

Authors:  Jiao Sun; Qing-Tao Meng; Yu-Wei Wang; Wei-Long Zhao; Feng-Zhi Sun; Ji-Hong Liu; Ji-Yi Liu
Journal:  J Cardiothorac Surg       Date:  2022-06-03       Impact factor: 1.522

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.